Related Experiment Video
Updated: Aug 14, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Potential predictive factors of osteoporosis in HIV-positive subjects
Alfonso Fausto1, Marco Bongiovanni, Paola Cicconi
1Department of Radiology, Policlinico San Donato, University of Milan, Via Morandi, 30, 20097 San Donato Milanese, Milan, Italy. afausto@sirm.org
Insights
Nearly half of HIV-infected patients exhibit osteopenia or osteoporosis. Higher HIV-RNA levels, female gender, older age, and lower BMI predict bone disease, suggesting HIV itself may play a direct role.
Area of Science:
- Infectious Diseases
- Endocrinology
- Bone Metabolism
Background:
- Osteopenia and osteoporosis are frequently reported in HIV-infected individuals.
- The underlying mechanisms, whether viral or drug-related, remain unclear.
- Understanding these mechanisms is crucial for managing bone health in this population.
Purpose of the Study:
- To investigate the prevalence of osteopenia/osteoporosis in HIV-infected adults aged 30-50.
- To identify predictors of bone disease in this cohort, including traditional risk factors and HIV-specific parameters.
- To explore the potential direct role of HIV infection in the development of bone disease.
Main Methods:
- A cohort of 161 HIV-infected outpatients (naive and HAART-treated) underwent interviews, blood/urine tests, and bone mineral density (BMD) measurements via DEXA.
- Data collected included medical history, lifestyle factors, bone metabolism markers, and HIV-RNA levels.
- Statistical analyses included logistic and linear regression to identify predictors and differences in BMD.
Main Results:
- Nearly half (49.7%) of the subjects presented with osteopenia/osteoporosis, with similar rates in naive (45.8%) and HAART-treated (51.3%) groups.
- Independent predictors of osteopenia/osteoporosis were female gender, older age, low body mass index, and higher HIV-RNA levels.
- Highly Active Antiretroviral Therapy (HAART) use and altered bone metabolism markers were not significantly associated with osteopenia/osteoporosis.
Conclusions:
- HIV-infected individuals exhibit a high frequency of osteopenia/osteoporosis.
- Traditional risk factors are predictive, but higher HIV-RNA levels suggest a potential direct role of HIV in bone disease.
- Further research is warranted to elucidate the direct impact of HIV on bone metabolism.
Abstract:
Recent reports showed a high frequency of osteopenia/osteoporosis in HIV-infected subjects. Mechanism on the basis of this alteration is still unclear, as the direct effect of virus or of antiretroviral drugs. One hundred sixty-one consecutive HIV-infected outpatients aged 30-50 years, both naive and HAART-treated for >1 year, were included. An interview questionnaire was performed to establish prior pathological, toxic, epidemiological histories, medications intake, physical activity and eating habits. Blood and urinary tests were checked to exclude concomitant diseases, as were markers of bone metabolism and vitamin D3-metabolites. Each subject underwent to a lumbar spine and left hipbone mineral density by DEXA, using WHO criteria for diagnosis of osteopenia/osteoporosis. Radiologist was unaware if the subject was receiving HAART or not. For groups' homogeneity Chi-square, Fisher's exact and Student's t tests were used. Logistic regression analysis was used to find predictors of osteopenia/osteoporosis and linear regression model to find differences in bone mass density. The demographic characteristics of the 48 naive subjects and the 113 on HAART were comparable. Eighty subjects (49.7%) showed osteopenia/osteoporosis: 22 (45.8%) naive and 58 (51.3%) on HAART (P = 0.46). Independent predictors of osteopenia/osteoporosis were female gender (OR: 3.02, 95% CI: 1.26-7.25, P = 0.01 vs. male), older age (OR: 1.10, 95% CI: 1.01-1.20, P = 0.03, for each additional year), low body mass index (OR: 0.78, 95% CI: 0.68-0.91, P = 0.001 for each additional unit) and higher HIV-RNA levels at DEXA (OR: 1.97, 95% CI: 1.16-3.34, P = 0.01 for each additional Log(10)), whereas the use of HAART (OR: 2.61, 95% CI: 0.66-10.27, P = 0.17 vs. naive) and the alterations of markers of bone metabolism were not significantly related to osteopenia/osteoporosis. Similar findings were obtained using linear regression model analysis. HIV-infected subjects have a high frequency of osteopenia/osteoporosis. Traditional risk factors are predictive of osteopenia/osteoporosis also in HIV-subjects; the association with higher HIV-RNA levels can suggest a direct role of HIV itself in the occurrence of bone disease.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...